[
    [
        {
            "time": "2021-04-20",
            "original_text": "智飞生物（300122）2020年年报及2021年一季报点评：业绩超市场预期，新冠疫苗业绩兑现【东吴医药朱国广团队】",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "一季报",
                    "新冠疫苗",
                    "业绩超预期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物（300122）2020年年报及2021年一季报点评：业绩超市场预期，新冠疫苗业绩兑现【东吴医药朱国广团队】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "太平洋 - 智飞生物：新冠疫苗放量在即，自研产品进入收获期【公司研究】",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "自研产品",
                    "放量在即"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "太平洋 - 智飞生物：新冠疫苗放量在即，自研产品进入收获期【公司研究】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "一季度多只医药股获明星基金增持",
            "features": {
                "keywords": [
                    "医药股",
                    "明星基金",
                    "增持"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一季度多只医药股获明星基金增持",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "山西证券：医药行业基本面良好，刚需带来确定性成长",
            "features": {
                "keywords": [
                    "医药行业",
                    "基本面",
                    "刚需",
                    "成长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "山西证券：医药行业基本面良好，刚需带来确定性成长",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "华西证券：智飞生物（300122.SZ）2021Q1业绩超预期，维持“买入”评级",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2021Q1",
                    "业绩超预期",
                    "买入评级"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华西证券：智飞生物（300122.SZ）2021Q1业绩超预期，维持“买入”评级",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "最新！傅鹏博、谢治宇、朱少醒、邓晓峰持股变动名单",
            "features": {
                "keywords": [
                    "傅鹏博",
                    "谢治宇",
                    "朱少醒",
                    "邓晓峰",
                    "持股变动"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "最新！傅鹏博、谢治宇、朱少醒、邓晓峰持股变动名单",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "平安证券 - 生物医药行业周报：第五批药品国采数据流出，集采成为常态符合预期【行业研究】",
            "features": {
                "keywords": [
                    "生物医药",
                    "第五批药品国采",
                    "集采",
                    "常态"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "平安证券 - 生物医药行业周报：第五批药品国采数据流出，集采成为常态符合预期【行业研究】",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]